Technical Analysis for PODD - Insulet Corporation

Grade Last Price % Change Price Change
grade B 121.145 0.74% 0.90
PODD closed down 2.87 percent on Friday, July 12, 2019, on 63 percent of normal volume. The bulls were able to push the stock to a new 52-week high. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Earnings due: Aug 5

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical PODD trend table...

Date Alert Name Type % Chg
Slingshot Bullish Bullish Swing Setup 0.74%
Bollinger Band Squeeze Range Contraction 0.74%
Three Weeks Tight Range Contraction 0.74%
New 52 Week High Strength 0.74%
BB Squeeze + Upper Band Touch Range Contraction 0.74%
Outside Day Range Expansion 0.74%
Overbought Stochastic Strength 0.74%
Upper Bollinger Band Touch Strength 0.74%
New 52 Week Closing High Bullish -2.14%
Bollinger Band Squeeze Range Contraction -2.14%

Older signals for PODD ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Insulet Corporation, a medical device company, engages in the development, manufacture, and sale of insulin infusion systems for people with insulin-dependent diabetes in the United States. The company offers OmniPod Insulin Management System (OmniPod System), which consists of the OmniPod disposable insulin infusion device and the handheld wireless personal diabetes manager to provide diabetes management solution for people with insulin-dependent diabetes. It is also involved in the distribution of durable medical equipment, including blood glucose testing supplies, insulin pumps, pump supplies, pharmaceuticals, and other products for the management and treatment of diabetes. The company sells its OmniPod System directly to patients through referrals from healthcare professionals and through patient leads, as well as through third-party distributors; and delivers durable medical equipment to endocrinologists, insurers, and clients. Insulet Corporation was founded in 2000 and is headquartered in Bedford, Massachusetts.
Medicine Pharmaceuticals Diabetes Endocrine System Healthcare Professionals Diabetes Mellitus Insulin Treatment Of Diabetes Endocrinology Durable Medical Equipment Diabetes Management Insulin Dependent Diabetes Insulin Pump Minimed Paradigm
Is PODD a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 124.38
52 Week Low 70.8
Average Volume 560,267
200-Day Moving Average 92.6065
50-Day Moving Average 111.3996
20-Day Moving Average 118.7265
10-Day Moving Average 119.868
Average True Range 3.3383
ADX 34.16
+DI 28.6819
-DI 15.2577
Chandelier Exit (Long, 3 ATRs ) 114.3651
Chandelier Exit (Short, 3 ATRs ) 120.0649
Upper Bollinger Band 123.0051
Lower Bollinger Band 114.4479
Percent B (%b) 0.68
BandWidth 7.207489
MACD Line 2.8284
MACD Signal Line 3.0336
MACD Histogram -0.2052
Fundamentals Value
Market Cap 6.98 Billion
Num Shares 58 Million
EPS -0.52
Price-to-Earnings (P/E) Ratio -231.25
Price-to-Sales 8.29
Price-to-Book 52.47
PEG Ratio -4.59
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 126.82
Resistance 3 (R3) 127.47 125.92 125.73
Resistance 2 (R2) 125.92 124.25 125.60 125.36
Resistance 1 (R1) 123.09 123.22 122.32 122.44 124.99
Pivot Point 121.54 121.54 121.16 121.22 121.54
Support 1 (S1) 118.71 119.87 117.94 118.06 115.51
Support 2 (S2) 117.16 118.84 116.84 115.14
Support 3 (S3) 114.33 117.16 114.78
Support 4 (S4) 113.68